Sep 21, 2020 / 07:00PM GMT
Presentations - Conference Call
Sep 21, 2020 / 07:00PM GMT
=====================
Corporate Participants
=====================
* Anne E. White
Eli Lilly and Company - Senior VP & President of Lilly Oncology
* Daniel M. Skovronsky
Eli Lilly and Company - Senior VP, Chief Scientific Officer & President of Lilly Research Labs
* Jacob S. Van Naarden
Loxo Oncology, Inc. - COO
* Martin Frenzel
Eli Lilly and Company - Principal Research Scientist of Oncology
* Maura Dickler
Eli Lilly and Company - VP of Oncology Late-Stage Development
* Mike Czapar
Eli Lilly and Company - Director of IR
=====================
Conference Call Participants
=====================
* Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
* Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
* Geoffrey Christopher Meacham
BofA Merrill Lynch, Research Division - Research Analyst
* Jonathan Lim
UBS
Eli Lilly and Co
(MIL:1LLY)
€
1,037.4
-22.4 (-2.11%)
Market Cap: 930.72 Bil
Enterprise Value: 964.17 Bil
PE Ratio: 42.22
PB Ratio: 34.04
GF Score: 76/100 Eli Lilly and Co to Discuss ESMO 2020 Presentations - Conference Call Transcript
Sep 21, 2020 / 07:00PM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot